Leading the way in new study options rooted in the 3Rs with genetic toxicology and in vitro alternatives

Cary Johnson

Cary Johnson is a board-certified pathologist with the certifications in Anatomic and Clinical Pathology. Before joining Dianon Pathology, he served as a pathologist in several hospitals and private lab settings the last of which was in the University of California system of hospitals with the assignment of full Professor of Pathology.

Leveraging global laboratory scale to deliver critical patient test results on time

Physicians attending to critically ill cancer patients awaited test results from Labcorp's Los Angeles Center of Excellence for Advanced Anatomic Pathology and Histology. These results would determine patients’ eligibility for enrollment in clinical trials that could positively impact the progression of their disease. Unfortunately, the Labcorp laboratory team encountered an unexpected issue with the performance of certain lots of testing reagents.

Labcorp Announces Retirement of Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard from Its Board of Directors

BURLINGTON, N.C., May 16, 2024 — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that Dr. R. Sanders Williams and Mr. Jean-Luc Bélingard have retired from its board of directors at the conclusion of their current terms on May 14, 2024. Dr.

Leading through a lab management transition: Fireside chat with Lugard Igharo, regional lab director and former Ascension employee

Lu Igharo, regional lab director, Labcorp (formerly Ascension), and Bryan Vaughn, senior vice president of health systems, Labcorp, discuss the Ascension and Labcorp lab management transition process, including the Ascension lab team’s initial reaction to the partnership announcement and how the sentiment has grown to be overwhelmingly positive in the time since. 

Automation advancements at our central laboratory

See how state-of-the-art technologies at our Indianapolis central lab enhance sample processing to better support of your mission and bring new therapeutics to patients.

Innovation in action at our central laboratory

Our new automation integrates robotic sample processing and pre-analytical tasks like centrifugation to enable seamless progression of samples through the lab. Watch the video to learn more about our latest investments in lab automation.

Inside our automated central lab

Get an inside look at our central laboratory in Indianapolis to see how new automation is improving efficiency and capacity in our hematology and testing labs.

Labcorp Introduces First Trimester Screening Test to Assess Preeclampsia Risk during Pregnancy

Labcorp is now the only lab that can detect preeclampsia risk across all pregnancy trimesters BURLINGTON, N.C. , May 15, 2024 /PRNewswire/ --  Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of its first trimester preeclampsia

Overcoming key challenges in global cell and gene therapy trials with Labcorp

Cell and gene therapies (CGT) represent the future of precision medicine, offering the potential to improve patient outcomes across a range of diseases. However, bringing these complex therapies from bench to bedside presents unique challenges at every stage of development. As the CGT landscape continues to evolve rapidly, developers need an experienced partner who can provide integrated solutions to overcome key hurdles at every stage from early research through commercialization. In a recent presentation for the Korea Biomedicine Industry Association (KoBIA), Maryland Franklin, PhD, vice president and enterprise head of CGT at Labcorp, shared how Labcorp’s comprehensive CGT capabilities support all aspects of global CGT development, including preclinical pharmacology, companion diagnostics (CDx) development and validation.